168 related articles for article (PubMed ID: 37304538)
21. Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme.
Li Y; Ma K; Xie Q; Zhang X; Zhang X; Chen K; Kong L; Qian R
Onco Targets Ther; 2021; 14():5183-5195. PubMed ID: 34737577
[TBL] [Abstract][Full Text] [Related]
22. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
23. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
PeerJ; 2022; 10():e12768. PubMed ID: 35111402
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Gene Co-Expression Network to Identify the Role of CD8 + T Cell Infiltration-Related Biomarkers in High-Grade Glioma.
Feng P; Li Y; Tian Z; Qian Y; Miao X; Zhang Y
Int J Gen Med; 2022; 15():1879-1890. PubMed ID: 35228815
[TBL] [Abstract][Full Text] [Related]
25. Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma.
Ren W; Jin W; Liang Z
Front Neurol; 2022; 13():832944. PubMed ID: 35370869
[TBL] [Abstract][Full Text] [Related]
26. Co-expression prognostic-related genes signature base on propofol and sevoflurane anesthesia predict prognosis and immunotherapy response in glioblastoma.
Hou Z; Luo D; Luo H; Hui Q; Xu Y; Lin X; Xu Z
Ann Med; 2023 Dec; 55(1):778-792. PubMed ID: 36856519
[TBL] [Abstract][Full Text] [Related]
27. A Promising Glycolysis- and Immune-Related Prognostic Signature for Glioblastoma.
Wang F; Liu X; Jiang H; Chen B
World Neurosurg; 2022 May; 161():e363-e375. PubMed ID: 35144031
[TBL] [Abstract][Full Text] [Related]
28. Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
Oncol Lett; 2021 Jan; 21(1):22. PubMed ID: 33240428
[TBL] [Abstract][Full Text] [Related]
29. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q
Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.
Wang W; Zhao Z; Wu F; Wang H; Wang J; Lan Q; Zhao J
J Neurooncol; 2018 Feb; 136(3):495-503. PubMed ID: 29168084
[TBL] [Abstract][Full Text] [Related]
31. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
Jia D; Li S; Li D; Xue H; Yang D; Liu Y
Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997
[TBL] [Abstract][Full Text] [Related]
32. Chromobox 7/8 serve as independent indicators for glioblastoma
Zheng ZQ; Yuan GQ; Kang NL; Nie QQ; Zhang GG; Wang Z
Front Neurol; 2022; 13():912039. PubMed ID: 36034290
[TBL] [Abstract][Full Text] [Related]
33. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
[TBL] [Abstract][Full Text] [Related]
34. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H
Front Oncol; 2020; 10():590352. PubMed ID: 33392085
[TBL] [Abstract][Full Text] [Related]
35. Identification of biomarkers and ceRNA network in glioblastoma through bioinformatic analysis and evaluation of potential prognostic values.
Hong F; Gong Z; Zhang X; Ma P; Yin Y; Wang H
Ann Transl Med; 2021 Oct; 9(20):1561. PubMed ID: 34790767
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics analysis of microenvironment-related genes associated with radioresistance in glioblastoma.
Liu Y; Zhao Y; Fang J; Fang J; Yuan X
Transl Cancer Res; 2020 Dec; 9(12):7495-7504. PubMed ID: 35117350
[TBL] [Abstract][Full Text] [Related]
37. Analysis and validation of aging-related genes in prognosis and immune function of glioblastoma.
Mu J; Gong J; Shi M; Zhang Y
BMC Med Genomics; 2023 May; 16(1):109. PubMed ID: 37208656
[TBL] [Abstract][Full Text] [Related]
38. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
Sun R; Pan Y; Mu L; Ma Y; Shen H; Long Y
Front Genet; 2021; 12():768930. PubMed ID: 34733320
[No Abstract] [Full Text] [Related]
39. Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis.
Zhang H; Bao M; Liao D; Zhang Z; Tian Z; Yang E; Luo P; Jiang X
Med Oncol; 2023 Apr; 40(6):161. PubMed ID: 37099121
[TBL] [Abstract][Full Text] [Related]
40. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
